Page last updated: 2024-10-28

hexamethonium and Cough

hexamethonium has been researched along with Cough in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HILLS, BR1
KELLY, JC1
Bolser, DC1
DeGennaro, FC1
O'Reilly, S1
Hey, JA1
Chapman, RW1

Other Studies

2 other studies available for hexamethonium and Cough

ArticleYear
Effect of hexamethonium iodide on lobeline-stimulated coughing.
    Glasgow medical journal, 1951, Volume: 32, Issue:3

    Topics: Bis-Trimethylammonium Compounds; Cough; Hexamethonium; Humans; Lobeline

1951
Pharmacological studies of allergic cough in the guinea pig.
    European journal of pharmacology, 1995, Apr-24, Volume: 277, Issue:2-3

    Topics: Administration, Oral; Aerosols; Albuterol; Analysis of Variance; Animals; Antitussive Agents; Capsai

1995